# Postmarketing Studies and  Clinical Trials—Implementation  of Section 505(o)(3) of the Federal Food, Drug, and Cosmetic Act Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/postmarketing-studies-and-clinical-trialsimplementation-of-section-505o3-of-the-federal-food-drug-and-cosmetic-act-guidance-for-industry/5ddef98b-24ad-4f80-a57b-2bd98fbf3a27

> FDA guidance document: Postmarketing Studies and  Clinical Trials—Implementation  of Section 505(o)(3) of the Federal Food, Drug, and Cosmetic Act Guidance for Industry. Issue date: April 12, 2011. Get complete insights and analysis.

---

## Details

- Title: Postmarketing Studies and  Clinical Trials—Implementation  of Section 505(o)(3) of the Federal Food, Drug, and Cosmetic Act Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2011-04-12
- Last Changed: 2021-05-12
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2009-D-0283">FDA-2009-D-0283</a>

## Related Documents

- [M3(R2)Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals: Questions and Answers](https://www.globalkeysolutions.net/guidances/guidance-document/m3r2nonclinical-safety-studies-for-the-conduct-of-human-clinical-trials-and-marketing-authorization-for-pharmaceuticals-questions-and-answers/04bea7cb-30a1-49e6-94c9-51131e6004d7)
- [Q11 Development and Manufacture of Drug Substances](https://www.globalkeysolutions.net/guidances/guidance-document/q11-development-and-manufacture-of-drug-substances/8d1aacb1-7da4-42f7-9a3a-18b2fc871411)
- [M3(R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals](https://www.globalkeysolutions.net/guidances/guidance-document/m3r2-nonclinical-safety-studies-for-the-conduct-of-human-clinical-trials-and-marketing-authorization-for-pharmaceuticals/fab84a39-1f07-487f-ae13-2eb2b1884d18)